Nurturing innovation through mergers
This article was originally published in Scrip
Executive Summary
Following the latest round of pharma mergers and as a long-time participant in this industry-shaping activity, I was recently asked: “Do mergers hurt innovation?”
You may also be interested in...
CEO CORNER: A new blog feature with Fred Hassan
I have returned from the PhRMA Annual Meeting in San Diego. My recent book was handed out to all registrants of the meeting and I got to hear from many of them. I appreciate feedback. And the takeaways from my book are the same as my own personal playbook.
Lessons in Lifecycle Management: Successors, Flankers and Toppers
Successors, flankers and toppers are product lifecycle management (LCM) categories used by pharma executives, although they may be referred to differently by other companies.
Fred Hassan: Getting traction with lifecycle management
Early in my career, I learned the essential principle of product lifecycle management (LCM): "Do LCM because you create value for the patient or the customer – not just because you want to get more profit out of each molecule."